Literature DB >> 27630529

ESMO World Congress on Gastrointestinal Cancer And European Post-Chicago Melanoma/Skin Cancer Meeting.

Walter Alexander.   

Abstract

We present sessions on the latest trials and treatments for colorectal cancer from the ESMO World Congress and report on new developments in diagnostics and therapy presented at the European Post-Chicago Melanoma/Skin Cancer Meeting.

Entities:  

Year:  2016        PMID： 27630529      PMCID： PMC5010272     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  3 in total

1.  SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.

Authors:  Guy A van Hazel; Volker Heinemann; Navesh K Sharma; Michael P N Findlay; Jens Ricke; Marc Peeters; David Perez; Bridget A Robinson; Andrew H Strickland; Tom Ferguson; Javier Rodríguez; Hendrik Kröning; Ido Wolf; Vinod Ganju; Euan Walpole; Eveline Boucher; Thomas Tichler; Einat Shacham-Shmueli; Alex Powell; Paul Eliadis; Richard Isaacs; David Price; Fred Moeslein; Julien Taieb; Geoff Bower; Val Gebski; Mark Van Buskirk; David N Cade; Kenneth Thurston; Peter Gibbs
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

2.  A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.

Authors:  I Chau; A R Norman; D Cunningham; D Tait; P J Ross; T Iveson; M Hill; T Hickish; F Lofts; D Jodrell; A Webb; J R Oates
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

3.  Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.

Authors:  A Saini; A R Norman; D Cunningham; I Chau; M Hill; D Tait; T Hickish; T Iveson; F Lofts; D Jodrell; P J Ross; J Oates
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640
  3 in total
  1 in total

Review 1.  The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.

Authors:  Ibrahim Ragab Eissa; Itzel Bustos-Villalobos; Toru Ichinose; Shigeru Matsumura; Yoshinori Naoe; Noriyuki Miyajima; Daishi Morimoto; Nobuaki Mukoyama; Wu Zhiwen; Maki Tanaka; Hitoki Hasegawa; Seiji Sumigama; Branko Aleksic; Yasuhiro Kodera; Hideki Kasuya
Journal:  Cancers (Basel)       Date:  2018-09-26       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.